Sofinnova Partners, a European venture capital firm specializing in life sciences funding, has expanded its investment activity to include digital medicine startups, starting with three European companies in whose financings the firm has taken leading roles.
Paris-based Sofinnova Partners announced last week that it has launched a new strategy aimed at investing in a new breed of startups that straddle the lines between data and biology.